Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Jul;85(2):199–203. doi: 10.1054/bjoc.2001.1888

Frequent loss of expression without sequence mutations of the DCC gene in primary gastric cancer

K Sato 1,2, G Tamura 1, T Tsuchiya 1, Y Endoh 1, O Usuba 2, W Kimura 2, T Motoyama 1
PMCID: PMC2364029  PMID: 11461076

Abstract

Loss of heterozygosity (LOH) on chromosome 18q21 is frequently found in various human cancers, suggesting the presence of tumour suppressor gene(s) in this chromosomal region. DCC is the most likely target of LOH because loss or reduction of DCC expression has been found in many types of cancers. However, few reports have focused on sequence mutations of this gene. We investigated sequence mutations and expression of DCC in primary gastric cancers. We studied mutations in 25 of the 29 DCC exons by PCR-SSCP in 17 primary gastric cancers exhibiting LOH on 18q21. No mutations of DCC were found in any of the tumours, although 78% (47/60) of the primary tumours showed apparent loss or reduction of DCC expression by immunohistochemistry. Analysis of methylation status of DCC revealed that methylation frequently occurred in both primary tumours (75%; 45/60) and corresponding non-cancerous gastric mucosae (72%; 43/60). Methylated status of DCC was significantly correlated with the loss of DCC expression in primary tumours (P< 0.01). These results indicate that DCC is frequently silenced, probably by epigenetic mechanisms instead of sequence mutations in gastric cancer. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: DCC, gastric cancer, mutation, methylation

Full Text

The Full Text of this article is available as a PDF (170.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahuja N., Li Q., Mohan A. L., Baylin S. B., Issa J. P. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res. 1998 Dec 1;58(23):5489–5494. [PubMed] [Google Scholar]
  2. Baylin S. B., Herman J. G., Graff J. R., Vertino P. M., Issa J. P. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res. 1998;72:141–196. [PubMed] [Google Scholar]
  3. Cho K. R., Oliner J. D., Simons J. W., Hedrick L., Fearon E. R., Preisinger A. C., Hedge P., Silverman G. A., Vogelstein B. The DCC gene: structural analysis and mutations in colorectal carcinomas. Genomics. 1994 Feb;19(3):525–531. doi: 10.1006/geno.1994.1102. [DOI] [PubMed] [Google Scholar]
  4. Deng G., Chen A., Hong J., Chae H. S., Kim Y. S. Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Cancer Res. 1999 May 1;59(9):2029–2033. [PubMed] [Google Scholar]
  5. Endoh Y., Tamura G., Watanabe H., Ajioka Y., Motoyama T. The common 18-base pair deletion at codons 418-423 of the E-cadherin gene in differentiated-type adenocarcinomas and intramucosal precancerous lesions of the stomach with the features of gastric foveolar epithelium. J Pathol. 1999 Oct;189(2):201–206. doi: 10.1002/(SICI)1096-9896(199910)189:2<201::AID-PATH409>3.0.CO;2-A. [DOI] [PubMed] [Google Scholar]
  6. Fearon E. R., Cho K. R., Nigro J. M., Kern S. E., Simons J. W., Ruppert J. M., Hamilton S. R., Preisinger A. C., Thomas G., Kinzler K. W. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science. 1990 Jan 5;247(4938):49–56. doi: 10.1126/science.2294591. [DOI] [PubMed] [Google Scholar]
  7. Fleisher A. S., Esteller M., Wang S., Tamura G., Suzuki H., Yin J., Zou T. T., Abraham J. M., Kong D., Smolinski K. N. Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res. 1999 Mar 1;59(5):1090–1095. [PubMed] [Google Scholar]
  8. Graff J. R., Herman J. G., Myöhänen S., Baylin S. B., Vertino P. M. Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation. J Biol Chem. 1997 Aug 29;272(35):22322–22329. doi: 10.1074/jbc.272.35.22322. [DOI] [PubMed] [Google Scholar]
  9. Hahn S. A., Schutte M., Hoque A. T., Moskaluk C. A., da Costa L. T., Rozenblum E., Weinstein C. L., Fischer A., Yeo C. J., Hruban R. H. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science. 1996 Jan 19;271(5247):350–353. doi: 10.1126/science.271.5247.350. [DOI] [PubMed] [Google Scholar]
  10. Herman J. G., Graff J. R., Myöhänen S., Nelkin B. D., Baylin S. B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9821–9826. doi: 10.1073/pnas.93.18.9821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Herman J. G., Umar A., Polyak K., Graff J. R., Ahuja N., Issa J. P., Markowitz S., Willson J. K., Hamilton S. R., Kinzler K. W. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6870–6875. doi: 10.1073/pnas.95.12.6870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hiltunen M. O., Alhonen L., Koistinaho J., Myöhänen S., Päkkönen M., Marin S., Kosma V. M., Jänne J. Hypermethylation of the APC (adenomatous polyposis coli) gene promoter region in human colorectal carcinoma. Int J Cancer. 1997 Mar 17;70(6):644–648. doi: 10.1002/(sici)1097-0215(19970317)70:6<644::aid-ijc3>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  13. Ikeda Y., Mori M., Kamakura T., Haraguchi Y., Saku M., Sugimachi K. Increased incidence of undifferentiated type of gastric cancer with tumor progression in 912 patients with early gastric cancer and 1245 with advanced gastric cancer. Cancer. 1994 May 15;73(10):2459–2463. doi: 10.1002/1097-0142(19940515)73:10<2459::aid-cncr2820731003>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  14. Kataoka M., Okabayashi T., Orita K. Decreased expression of DCC mRNA in gastric and colorectal cancer. Surg Today. 1995;25(12):1001–1007. doi: 10.1007/BF00311682. [DOI] [PubMed] [Google Scholar]
  15. Kohno T., Yokota J. How many tumor suppressor genes are involved in human lung carcinogenesis? Carcinogenesis. 1999 Aug;20(8):1403–1410. doi: 10.1093/carcin/20.8.1403. [DOI] [PubMed] [Google Scholar]
  16. Kong X. T., Choi S. H., Inoue A., Xu F., Chen T., Takita J., Yokota J., Bessho F., Yanagisawa M., Hanada R. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma. Cancer Res. 1997 Sep 1;57(17):3772–3778. [PubMed] [Google Scholar]
  17. Kuismanen S. A., Holmberg M. T., Salovaara R., Schweizer P., Aaltonen L. A., de La Chapelle A., Nyström-Lahti M., Peltomäki P. Epigenetic phenotypes distinguish microsatellite-stable and -unstable colorectal cancers. Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12661–12666. doi: 10.1073/pnas.96.22.12661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Maesawa C., Tamura G., Suzuki Y., Ogasawara S., Sakata K., Kashiwaba M., Satodate R. The sequential accumulation of genetic alterations characteristic of the colorectal adenoma-carcinoma sequence does not occur between gastric adenoma and adenocarcinoma. J Pathol. 1995 Jul;176(3):249–258. doi: 10.1002/path.1711760307. [DOI] [PubMed] [Google Scholar]
  19. Miyake S., Nagai K., Yoshino K., Oto M., Endo M., Yuasa Y. Point mutations and allelic deletion of tumor suppressor gene DCC in human esophageal squamous cell carcinomas and their relation to metastasis. Cancer Res. 1994 Jun 1;54(11):3007–3010. [PubMed] [Google Scholar]
  20. Nishizuka S., Tamura G., Maesawa C., Sakata K., Suzuki Y., Iwaya T., Terashima M., Saito K., Satodate R. Analysis of the DPC4 gene in gastric carcinoma. Jpn J Cancer Res. 1997 Apr;88(4):335–339. doi: 10.1111/j.1349-7006.1997.tb00385.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Nishizuka S., Tamura G., Terashima M., Satodate R. Loss of heterozygosity during the development and progression of differentiated adenocarcinoma of the stomach. J Pathol. 1998 May;185(1):38–43. doi: 10.1002/(SICI)1096-9896(199805)185:1<38::AID-PATH58>3.0.CO;2-T. [DOI] [PubMed] [Google Scholar]
  22. Schmitt C. A., Thaler K. R., Wittig B. M., Kaulen H., Meyer zum Büschenfelde K. H., Dippold W. G. Detection of the DCC gene product in normal and malignant colorectal tissues and its relation to a codon 201 mutation. Br J Cancer. 1998 Feb;77(4):588–594. doi: 10.1038/bjc.1998.95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Stirzaker C., Millar D. S., Paul C. L., Warnecke P. M., Harrison J., Vincent P. C., Frommer M., Clark S. J. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors. Cancer Res. 1997 Jun 1;57(11):2229–2237. [PubMed] [Google Scholar]
  24. Tamura G., Kihana T., Nomura K., Terada M., Sugimura T., Hirohashi S. Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis. Cancer Res. 1991 Jun 1;51(11):3056–3058. [PubMed] [Google Scholar]
  25. Tamura G. Molecular pathogenesis of adenoma and differentiated adenocarcinoma of the stomach. Pathol Int. 1996 Nov;46(11):834–841. doi: 10.1111/j.1440-1827.1996.tb03556.x. [DOI] [PubMed] [Google Scholar]
  26. Tamura G., Sakata K., Maesawa C., Suzuki Y., Terashima M., Satoh K., Sekiyama S., Suzuki A., Eda Y., Satodate R. Microsatellite alterations in adenoma and differentiated adenocarcinoma of the stomach. Cancer Res. 1995 May 1;55(9):1933–1936. [PubMed] [Google Scholar]
  27. Tamura G., Sakata K., Nishizuka S., Maesawa C., Suzuki Y., Iwaya T., Terashima M., Saito K., Satodate R. Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines. Jpn J Cancer Res. 1996 Nov;87(11):1153–1159. doi: 10.1111/j.1349-7006.1996.tb03125.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Tamura G., Sakata K., Nishizuka S., Maesawa C., Suzuki Y., Terashima M., Eda Y., Satodate R. Allelotype of adenoma and differentiated adenocarcinoma of the stomach. J Pathol. 1996 Dec;180(4):371–377. doi: 10.1002/(SICI)1096-9896(199612)180:4<371::AID-PATH704>3.0.CO;2-2. [DOI] [PubMed] [Google Scholar]
  29. Tamura G., Yin J., Wang S., Fleisher A. S., Zou T., Abraham J. M., Kong D., Smolinski K. N., Wilson K. T., James S. P. E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst. 2000 Apr 5;92(7):569–573. doi: 10.1093/jnci/92.7.569. [DOI] [PubMed] [Google Scholar]
  30. Toyota M., Ahuja N., Suzuki H., Itoh F., Ohe-Toyota M., Imai K., Baylin S. B., Issa J. P. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res. 1999 Nov 1;59(21):5438–5442. [PubMed] [Google Scholar]
  31. Tsuchiya T., Tamura G., Sato K., Endoh Y., Sakata K., Jin Z., Motoyama T., Usuba O., Kimura W., Nishizuka S. Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia. Oncogene. 2000 Jul 27;19(32):3642–3646. doi: 10.1038/sj.onc.1203704. [DOI] [PubMed] [Google Scholar]
  32. Uchino S., Tsuda H., Noguchi M., Yokota J., Terada M., Saito T., Kobayashi M., Sugimura T., Hirohashi S. Frequent loss of heterozygosity at the DCC locus in gastric cancer. Cancer Res. 1992 Jun 1;52(11):3099–3102. [PubMed] [Google Scholar]
  33. Wu M. S., Shun C. T., Wang H. P., Sheu J. C., Lee W. J., Wang T. H., Lin J. T. Genetic alterations in gastric cancer: relation to histological subtypes, tumor stage, and Helicobacter pylori infection. Gastroenterology. 1997 May;112(5):1457–1465. doi: 10.1016/s0016-5085(97)70071-4. [DOI] [PubMed] [Google Scholar]
  34. Yoshida Y., Itoh F., Endo T., Hinoda Y., Imai K. Decreased DCC mRNA expression in human gastric cancers is clinicopathologically significant. Int J Cancer. 1998 Dec 18;79(6):634–639. doi: 10.1002/(sici)1097-0215(19981218)79:6<634::aid-ijc14>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES